TCRT News
High-Stakes Corporate Stories Putting Strategic Moves in the Spotlight
Today's corporate developments highlight some very different investment narratives: NeOnc Technologies Holdings (NASDAQ:NTHI) is pursuing new avenues for experimental brain-cancer treatments, Alector (NASDAQ:ALEC) is raising fresh capital for neurological disease research, Alaunos Therapeutics (NASDAQ:TCRT) is repositioning around pulmonary hypertension through a major acquisition, Zenta Group (NASDAQ:ZTG) is pursuing an artificial intelligence and data-services strategy, and Exascale Labs (NASDAQ:XLAB) is seeking to convert surging AI-computing demand into commercial growth.
24-7 Market News
High-Stakes Corporate Stories Putting Strategic Moves in the Spotlight
Today's corporate developments highlight some very different investment narratives: NeOnc Technologies Holdings (NASDAQ:NTHI) is pursuing new avenues for experimental brain-cancer treatments, Alector (NASDAQ:ALEC) is raising fresh capital for neurological disease research, Alaunos Therapeutics (NASDAQ:TCRT) is repositioning around pulmonary hypertension through a major acquisition, Zenta Group (NASDAQ:ZTG) is pursuing an artificial intelligence and data-services strategy, and Exascale Labs (NASDAQ:XLAB) is seeking to convert surging AI-computing demand into commercial growth.
24-7 Market News
Alaunos’ $350 Million Velaris Deal Targets New Frontier in Pulmonary Hypertension
Alaunos Therapeutics (NASDAQ:TCRT) completed its acquisition of Velaris Therapeutics and secured approximately $350 million in gross private-placement proceeds, setting up an aggressive push into pulmonary arterial hypertension (PAH) with a clinical pipeline targeting multiple disease-driving pathways.
24-7 Market News
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers
Alaunos Therapeutics (NASDAQ:TCRT) stock rose 34.9% to $2.94 during Thursday's after-market session. The market value of their outstanding shares is at $7.6 million.
Senti Biosciences (NASDAQ:SNTI) stockread more...
Benzinga
Wall Street’s Next Movers
The market is serving up a powerful mix of movers, including Alaunos Therapeutics (NASDAQ:TCRT) completed a major acquisition backed by a $350 million private placement, while NeOnc Technologies Holdings (NASDAQ:NTHI) is preparing for an important FDA discussion. Verastem Oncology (NASDAQ:VSTM) reported fresh cancer-drug results alongside a major financing and leadership transition, and Liquidia (NASDAQ:LQDA) resolved a prolonged legal battle over its pulmonary-hypertension treatment. Bending Spoons (NASDAQ:BSP) is attracting another major investment from Berkshire Hathaway.
24-7 Market News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Alaunos Therapeutics (NASDAQ:TCRT) shares rose 20.5% to $3.65 during Tuesday's after-market session. The market value of their outstanding shares is at $2.6 million.
Circle8 Group (NASDAQ:CIRC) stock movedread more...
Benzinga
Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday?
Alaunos Therapeutics acquired Velaris and raised $350 million to advance clinical therapies for pulmonary arterial hypertension through 2029.read more...
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers
Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million.
Picard Medical (AMEX:PMI) stock movedread more...
Benzinga
Market Moves Investors Can’t Ignore
Five companies, six developing stories, including Totaligent (OTCID:TGNT), Fermi America (NASDAQ:FRMI), Advanced Micro Devices (NASDAQ:AMD), Alaunos Therapeutics (NASDAQ:TCRT), BIO-key International (NASDAQ:BKYI), and Bumble (NASDAQ:BMBL).
24-7 Market News
Paragon Recruits Apogee’s Former Leaders After $10.9 Billion AbbVie Buyout
Alaunos Therapeutics (NASDAQ:TCRT) has completed its acquisition of Velaris Therapeutics, a privately held biotech developing treatments for pulmonary arterial hypertension (PAH) and related cardiopulmonary diseases. Velaris is the ninth company built around assets discovered by Paragon and the first launched with support from Paragon’s expanded leadership team.
24-7 Market News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers
Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-market session. The company's market cap stands at $2.6 million.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock roseread more...
Benzinga